Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Panic Disorder01:27

Panic Disorder

615
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
615
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

976
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
976
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

1.0K
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
1.0K
Anxiolytic Drugs: Benzodiazepines and Buspirone01:29

Anxiolytic Drugs: Benzodiazepines and Buspirone

2.3K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
2.3K
Chemical Factors Affecting Respiration Centers01:31

Chemical Factors Affecting Respiration Centers

2.1K
Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated....
2.1K
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

1.5K
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing psychiatric care through neuromodulation: From translational research to clinical practice.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026
Same author

Comparison of Quality of Life Between Patients with Chronic Unilateral Vestibular Hypofunction and Bilateral Vestibulopathy.

The journal of international advanced otology·2026
Same author

Shared genetic architecture between Alzheimer's disease and brain morphology.

Alzheimer's research & therapy·2026
Same author

Trans-ethnic estimation and implications of genetic impact on continuous glycemic profiles.

Cell discovery·2026
Same author

Back-transformations in random-effects meta-analysis-Impact and interpretation.

Research synthesis methods·2026
Same author

Local chemoarchitecture explains widespread lower cortical thickness associated with clinical high risk for psychosis.

Molecular psychiatry·2026

Related Experiment Video

Updated: Jan 13, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K

Pharmacological effects on 35% CO2 panic induction: A meta-analysis.

Jette H de Vos1, Alissa Haj Yahya1, Wolfgang Viechtbauer1

  • 1Department of Psychiatry and Neuropsychology, Mental Health and Neuroscience Research Institute (MHeNs), Maastricht University, the Netherlands.

Journal of Psychopharmacology (Oxford, England)
|October 29, 2025
PubMed
Summary

Pharmacological interventions significantly reduce anxiety and panic attack symptoms induced by CO2 inhalation. This supports using the CO2 challenge as a model to study panic disorder treatments.

Keywords:
carbon dioxideemotionspanic attackspsychopharmacology

More Related Videos

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

32.5K
Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
07:54

Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test

Published on: June 29, 2018

14.2K

Related Experiment Videos

Last Updated: Jan 13, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K
Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements
05:42

Elevated Plus Maze Test Combined with Video Tracking Software to Investigate the Anxiolytic Effect of Exogenous Ketogenic Supplements

Published on: January 7, 2019

32.5K
Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test
07:54

Testing Animal Anxiety in Rats: Effects of Open Arm Ledges and Closed Arm Wall Transparency in Elevated Plus Maze Test

Published on: June 29, 2018

14.2K

Area of Science:

  • Psychopharmacology
  • Neuroscience
  • Clinical Psychology

Background:

  • Inhalation of 35% carbon dioxide (CO2) reliably triggers fear and physiological responses similar to panic attacks (PAs).
  • The CO2 model is crucial for studying panic disorder (PD) and evaluating pharmacological interventions.
  • Previous research has not comprehensively quantified the effects of various drugs on CO2-induced panic responses.

Purpose of the Study:

  • To systematically quantify the impact of pharmacological interventions on the physiological and psychological responses to 35% CO2 inhalation.
  • To consolidate evidence from existing studies to provide a robust estimate of treatment effects.
  • To assess the efficacy of different drug classes in mitigating experimental panic.

Main Methods:

  • A systematic literature search was conducted to identify relevant peer-reviewed studies.
  • Multilevel meta-analyses were employed to synthesize data from 36 studies involving 980 participants.
  • Effect sizes were calculated for self-reported anxiety and panic attack symptoms following pharmacological interventions.

Main Results:

  • Pharmacological interventions aimed at symptom reduction significantly decreased induced anxiety (effect size = -0.55) and panic attack symptoms (effect size = -0.31).
  • Interventions targeting the serotonergic system demonstrated a pronounced reduction in induced anxiety (effect size = -0.81).
  • Data from 980 participants (patients with panic disorder and healthy controls) were analyzed.

Conclusions:

  • The findings support the utility of the 35% CO2 challenge as a valid experimental model for investigating panic disorder.
  • Specific pharmacological agents can effectively reduce sensitivity to CO2-induced panic, validating their therapeutic potential.
  • This meta-analysis provides quantitative evidence for the role of specific drug mechanisms in modulating panic responses.